Literature DB >> 32087775

Community burden and transmission of acute gastroenteritis caused by norovirus and rotavirus in the Netherlands (RotaFam): a prospective household-based cohort study.

Franke A Quee1, Marieke L A de Hoog1, Rob Schuurman2, Patricia Bruijning-Verhagen3.   

Abstract

BACKGROUND: Norovirus and rotavirus are the dominant pathogens causing acute gastroenteritis in children. To quantify their natural disease burden and transmission, we prospectively monitored households in an endemic setting in the Netherlands, a high-income country that does not have a rotavirus vaccination programme.
METHODS: We did a prospective, household survey-based cohort study in the Netherlands. Randomly selected households from the Dutch Population Register were invited to participate if they had at least three household members, including a child younger than 2 years. A member of each household was asked to record the gastrointestinal symptoms of all household members every day for 10 consecutie weeks using an interactive smartphone application. Real-time detection of acute gastroenteritis onset on the basis of entered symptoms activated requests for the case and one other household member to complete disease questionnaires and provide stool samples. Stool samples were analysed by real-time PCR for norovirus, rotavirus, adenovirus 40/41, and astrovirus. We calculated the per-pathogen proportion of households with at least one secondary acute gastroenteritis episode (epidemiologically but not microbiologically linked), the probability of a secondary episode in household members at risk (secondary attack rate), and the microbiologically confirmed symptomatic and asymptomatic transmission rates.
FINDINGS: During two seasons (January to March) in 2016 and 2017, 30 660 households were invited to participate, of which 604 households including 2298 individuals were enrolled. 697 acute gastroenteritis episodes were detected in 358 households, with samples obtained from 609 (87%) of 697 episodes. Norovirus (150 [25%] of 609 cases) and rotavirus (91 [15%] cases) were most frequently detected. Astrovirus was detected in 50 (8%) samples and adenovirus 40/41 in 24 (4%) samples. Overall disease severity was higher in patients with rotavirus-positive acute gastroenteritis than those with norovirus-positive acute gastroenteritis. Norovirus led to higher disease burden in adults than did rotavirus. Following an index case, a secondary acute gastroenteritis episode occurred in 34 (35%) of 96 households for norovirus and 26 (46%) of 56 households for rotavirus. Secondary attack rates were 15% (37 of 244 participants) for norovirus and 28% (33 of 120 participants) for rotavirus and asymptomatic transmission rates were 51% (52 of 102 household members) for norovirus and 22% (12 of 55 household members) for rotavirus. The microbiologically confirmed symptomatic transmission rate for norovirus was 10% (25 of 254 household members) and 18% for rotavirus (21 of 119 household members).
INTERPRETATION: In households with young family members in a setting without rotavirus vaccination, norovirus is the dominant acute gastroenteritis pathogen, but rotavirus is associated with more severe disease. There was substantial within-household transmission, both symptomatic and asymptomatic. The study provides key quantities on transmission, which can inform vaccine policy decisions and act as a baseline for impact evaluations in high-income settings. FUNDING: The Netherlands Organisation for Health Research and Development (grant 91616158).
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32087775     DOI: 10.1016/S1473-3099(20)30058-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  7 in total

1.  Burden of rotavirus gastroenteritis on caregivers: Findings from a systematic literature review.

Authors:  Cristina Carias; Tianyan Hu; Ya-Ting Chen
Journal:  Hum Vaccin Immunother       Date:  2022-04-04       Impact factor: 4.526

2.  Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study.

Authors:  Kathleen M O'Reilly; Frank Sandman; David Allen; Christopher I Jarvis; Amy Gimma; Amy Douglas; Lesley Larkin; Kerry L M Wong; Marc Baguelin; Ralph S Baric; Lisa C Lindesmith; Richard A Goldstein; Judith Breuer; W John Edmunds
Journal:  BMC Med       Date:  2021-11-09       Impact factor: 8.775

3.  Sapovirus, Norovirus and Rotavirus Detections in Stool Samples of Hospitalized Finnish Children With and Without Acute Gastroenteritis.

Authors:  Oskari Pitkänen; Jukka Markkula; Maria Hemming-Harlo
Journal:  Pediatr Infect Dis J       Date:  2022-05-01       Impact factor: 3.806

4.  Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members.

Authors:  Aaron C Miller; Alan T Arakkal; Daniel K Sewell; Alberto M Segre; Sriram V Pemmaraju; Philip M Polgreen
Journal:  Emerg Infect Dis       Date:  2022-05       Impact factor: 6.883

Review 5.  National Consensus for the Management of Acute Gastroenteritis in Jordanian Children: Consensus Recommendations Endorsed by the Jordanian Paediatric Society.

Authors:  Mohammed Rawashdeh; Basim Al-Zoubi; Maha Barbar Aliwat; Salma Burayzat; Esam Alhindawi; Ali Attia Al-Matti; Eyad Altamimi
Journal:  Int J Pediatr       Date:  2022-08-30

6.  Acute Gastroenteritis Disease Burden in Infants With Medical Risk Conditions in the Netherlands.

Authors:  Josephine A P van Dongen; Elsbeth D M Rouers; Rob Schuurman; Marc J M Bonten; Patricia Bruijning-Verhagen
Journal:  Pediatr Infect Dis J       Date:  2021-04-01       Impact factor: 3.806

Review 7.  Norovirus detection in wastewater and its correlation with human gastroenteritis: a systematic review and meta-analysis.

Authors:  Yue Huang; Nan Zhou; Shihan Zhang; Youqin Yi; Ying Han; Minqi Liu; Yue Han; Naiyang Shi; Liuqing Yang; Qiang Wang; Tingting Cui; Hui Jin
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-19       Impact factor: 5.190

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.